Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...

February 11, 2025 Novartis buys Blackstone's Anthos for up to $3.1 billion Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

Swiss pharmaceutical company Novartis is staying put at its Midtown office right next to Bryant Park. “We worked closely with Novartis to secure a new lease extension that addressed the firm’s current ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

A major shareholder of South City Projects, the consortium behind Kolkata's iconic South City Mall, has downplayed recent reports of a potential USD 400 million deal with alternative asset manager ...

Turn your Blackstone Griddle into an outdoor pizza oven with this Blackstone On-The-Go Pizza Oven Conversion Kit that’s marked down at Walmart. Walmart has the Blackstone 22-Inch On-the-Go Pizza ...

The REIT, backed by Blackstone Inc. and Sattva Developers Pvt., has offices in key Indian cities including Bengaluru, Mumbai, Hyderabad and Chennai. The proceeds from the sale would be used mostly ...

Blackstone closed this week on an $8 billion commercial real-estate debt fund, matching the record for this type of investment vehicle and offering another sign of a property-market rebound. The ...

Knowledge Realty Trust (KRT), a Real Estate Investment Trust (REIT) backed by Sattva Developers and Blackstone, on Thursday (March 6) filed its draft offer document for an initial public offering (IPO ...

A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis. With a dividend increase of 6.1% to CHF 3.50 per share, ...